AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. RBLX
3. AAPL
4. COIN
5. RDDT
6. WU
7. OLED
8. DXCM
9. NBIX
10. FND

Go back to AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Amgen Inc (NASDAQ: AMGN) Delayed: 387.64 --0 (-0%)
Previous Close $387.64    52 Week High $176.85 
Open $387.64    52 Week Low $133.64 
Day High $387.64    P/E 58.38 
Day Low $387.64    EPS $6.64 
Volume 3,020